AIM To investigate the safety and efficacy of S-1 plus oxaliplatin(SOX)as an adjuvant chemotherapy regimen in gastric cancer(GC)after D2 dissection.METHODS GC P
BACKGROUND Acquired factor V deficiency is a rare secondary hemorrhagic disease,which can lead to a severe bleeding disorder.CASE SUMMARY We report a 47-year-ol